Award
National Cancer Institute 1R01CA309039-01
Genome-Wide In Vivo CRISPR Screens in Human T Cells Identify GPCR Pathway Targets to Enhance CAR-T Therapies for Solid Tumors
Recipient
University of California, San Francisco
Award Amount
$680,597.00
Ceiling
$680,597.00
Awarded
March 25, 2026
Identifier
1R01CA309039-01
This award funds a research project at the University of California, San Francisco to use CRISPR screening in human T cells to find GPCR pathway targets that could improve CAR-T therapies for solid tumors.
Description
A research project funded by the National Cancer Institute (NCI) to conduct genome-wide in vivo CRISPR screens in human T cells to identify GPCR pathway targets to enhance CAR-T therapies for solid tumors.